HIN heartware international, inc
Add to My Watchlist 0.00% ! $2.37

heartware plummets

  1. Torbreck
    12,672 Posts.
    lightbulb Created with Sketch. 536
    clock Created with Sketch.
    18/04/11
    23:47
    Post #: 8285621
    BOSTON (MarketWatch) -- Shares of HeartWare International HTWR -15.28% plunged almost 20% to $68.39 in early action Monday. Late Friday, HeartWare released mixed study results for its HeartWare Ventricular Assist System heart pump in the treatment of patients with end-stage heart failure. HeartWare's negative news boosted shares of rival Thoratec Corp. THOR +14.84% , which markets a similar heart-pump called HeartMate II. Shares of Thoratec rallied 14% in early trading.


    http://www.marketwatch.com/story/heartware-thoratec-move-on-heart-pump-study-2011-04-18?link=MW_home_latest_news

    If only ventracor was still around... I cant believe how much management stuffed VCR up IMO
    HIN Price at posting: $2.20 Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back
right-arrow Created with Sketch.
NEWS Significant new gold-copper discovery at Minyari Dome delivers high-grade results
right-arrow Created with Sketch.
NEWS Strong Rock Chip Assays Include 18.4g/t Au from Waitekauri
right-arrow Created with Sketch.
NEWS Progress in Phelan-McDermid Syndrome Program to Be Presented at PMS Global Congress
right-arrow Created with Sketch.
AFP Combogesic IV Launches in Canada and R&D Shows Significant Advances
right-arrow Created with Sketch.
NEWS 30,000m Diamond Drilling Commences at Napie Gold Project
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.